{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:53:12Z","timestamp":1693554792014},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/internalmedicine.53.2094","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T23:28:43Z","timestamp":1413329323000},"page":"2347-2351","source":"Crossref","is-referenced-by-count":3,"title":["Long Progression-free Survival by Pemetrexed Continuation Maintenance Therapy Following Cisplatin-based Chemotherapy in Malignant Pleural Mesothelioma"],"prefix":"10.2169","volume":"53","author":[{"given":"Takayuki","family":"Takeda","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Uji Tokushukai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Itano","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Department of General Surgery, Uji Tokushukai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Fukita","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Uji Tokushukai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Uji Tokushukai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorou","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Internal Medicine, Uji Tokushukai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomized feasibility study. Lancet Oncol 12: 763-772, 2011."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636-2644, 2003.","DOI":"10.1200\/JCO.2003.11.136"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27: 3007-3013, 2009.","DOI":"10.1200\/JCO.2008.20.3943"},{"key":"4","unstructured":"4. Paz-Ares LG, de Marinis F, Dediu M, et al. PARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer. J Clin Oncol 31: 2895-2902, 2013."},{"key":"5","unstructured":"5. Chen CY, Chang YL, Shih JY, et al. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed. Lung Cancer 74: 132-138, 2011."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Sun JM, Han J, Ahn JS, Park K, Ahn MJ. Significance of thymidylate synthase and thyroid transcription factor 1 expression in patients with nonsquamous non-small cell lung cancer treated with pemetrexed-based chemotherapy. J Thorac Oncol 6: 1392-1399, 2011.","DOI":"10.1097\/JTO.0b013e3182208ea8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ozasa H, Oguri T, Uemura T, et al. Significance of thymidylate synthase for resistance to pemetrexed in lung cancer. Cancer Sci 101: 161-166, 2010.","DOI":"10.1111\/j.1349-7006.2009.01358.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Røe OD, Szulkin A, Anderssen E, et al. Molecular resistance fingerprint of pemetrexed and platinum in a long-term survivor of mesothelioma. PLoS One 7: e40521, 2012.","DOI":"10.1371\/journal.pone.0040521"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Scagliotti GV, Shin DM, Kindler HL, et al. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma. J Clin Oncol 21: 1556-1561, 2003.","DOI":"10.1200\/JCO.2003.06.122"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Olaussen KA, Dunant A, Fouret P, et al; IALT Bio Investigators. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med 355: 983-991, 2006.","DOI":"10.1056\/NEJMoa060570"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bogaert DPM, Pouw EM, Wijhe G, et al. Pemetrexed maintenance therapy in patients with malignant pleural mesothelioma. J Thorac Oncol 1: 25-30, 2006.","DOI":"10.1097\/01243894-200601000-00007"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.2094\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:51:50Z","timestamp":1621446710000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/53\/20\/53_53.2094\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":11,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.53.2094","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}